@xconomy.com 1 year ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@venturebeat.com 2 years ago
TwoXar raises $10 million from SoftBank, Andreessen Horowitz, and OS Fund to grow its AI drug discovery platform
@techcrunch.com 2 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas